Integral Derivatives’s Bausch Health BHC Stock Holding History

Integral Derivatives’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-34,053	Closed	-$540K	–	1131
2017 Q3	$488K	Buy	34,053 +13,139	+63%	+$199K	0.01%	739
2017 Q2	$362K	Buy	20,914 +2,565	+14%	+$30.7K	0.01%	803
2017 Q1	$202K	Buy	+18,349	New	+$252K	﹤0.01%	1019
2016 Q4	–	Sell	-18,491	Closed	-$339K	–	1133
2016 Q3	$454K	Buy	18,491 +2,576	+16%	+$66.7K	0.01%	664
2016 Q2	$321K	Sell	15,915 -10,057	-39%	-$285K	0.01%	728
2016 Q1	$683K	Buy	25,972 +2,672	+11%	+$198K	0.02%	453
2015 Q4	$2.37M	Buy	23,300 +14,318	+159%	+$1.61M	0.06%	235
2015 Q3	$1.6M	Buy	+8,982	New	+$2.09M	0.04%	366
2015 Q1	–	Sell	-4,270	Closed	-$757K	–	1103
2014 Q4	$611K	Buy	+4,270	New	+$574K	0.01%	846
2014 Q3	–	Sell	-13,388	Closed	-$1.6M	–	1398
2014 Q2	$1.69M	Buy	+13,388	New	+$1.71M	0.03%	491

Other funds holding BHC

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.63B AUM 5.11% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return

Integral Derivatives's BHC Position: Q4 2017 in Review

Integral Derivatives sold out of Bausch Health (BHC) in Q4 2017, closing a stake of 34,053 shares — an estimated $540K sold.

Integral Derivatives first reported a position in BHC in Q2 2014 and held it in 10 quarters. The position peaked at $2.37M in Q4 2015. 315 funds tracked by Wall St. Rank hold BHC as of Q4 2017.

Integral Derivatives reported no remaining Bausch Health position as of Q4 2017 after selling out during the quarter.
Integral Derivatives sold 34,053 Bausch Health shares in Q4 2017, an estimated $540K.
Integral Derivatives first reported a position in Bausch Health in Q2 2014 and held it in 10 quarters.
Integral Derivatives's Bausch Health position peaked at $2.37M in Q4 2015.
315 funds tracked by Wall St. Rank held Bausch Health as of Q4 2017.

Based on Integral Derivatives's 13F filing for Q4 2017, filed 14 Feb 2018.